Watercress: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Watercress is a plant. The parts that grow above the ground are used to make medicine.

Watercress is used for short-term swelling (inflammation) of the airways in the lungs (acute bronchitis), flu, arthritis, baldness, constipation, sexual arousal, and many other conditions, but there's no good scientific evidence to support these uses.

In foods, watercress is widely used in leaf salads and as a culinary spice.

Watercress may block some cancer-causing chemicals (carcinogens). It can also increase the amount of urine produced by the body (diuretic).

How does it work ?

Watercress may block some cancer-causing chemicals (carcinogens). It can also increase the amount of urine produced by the body (diuretic).

Uses & Effectiveness

Insufficient Evidence for

Arthritis.
Constipation.
Coughs.
Earaches.
Eczema (atopic dermatitis).
Flu.
Hair loss.
Itchy skin infection caused by mites (scabies).
Short-term swelling (inflammation) of the airways in the lungs (acute bronchitis).
Warts.
Other conditions.

More evidence is needed to rate the effectiveness of watercress for these uses.

Side Effects

When taken by mouth: Watercress is LIKELY SAFE in the amounts found in food. Watercress is POSSIBLY SAFE when taken by mouth in amounts used in medicine, short-term. When it is used long-term or in very large amounts, watercress is POSSIBLY UNSAFE and can cause damage to the stomach.

Special Precautions and Warnings

Pregnancy and breast-feeding: Watercress is LIKELY UNSAFE when used in medicinal amounts during pregnancy. It might start menstruation and cause a miscarriage. It's best to avoid use. There isn't enough reliable information to know if watercress is safe to use when breast-feeding. Stay on the safe side and avoid use.

Children: Watercress is LIKELY UNSAFE for use as a medicine in children, especially in those younger than four years old.

Stomach or intestinal ulcers: Don't use watercress if you have stomach or intestinal ulcers.

Kidney disease: Don't use watercress if you have kidney disease.

Interactions

Moderate Interaction

Be cautious with this combination

Warfarin (Coumadin) interacts with Watercress
Watercress contains large amounts of vitamin K. Vitamin K is used by the body to help blood clot. Warfarin (Coumadin) is used to slow blood clotting. By helping the blood clot, watercress might decrease the effectiveness of warfarin (Coumadin). Be sure to have your blood checked regularly. The dose of your warfarin (Coumadin) might need to be changed.
Chlorzoxazone (Parafon Forte, Paraflex) interacts with Watercress
The body breaks down chlorzoxazone to get rid of it. Watercress might decrease how quickly the body breaks down chlorzoxazone. Taking watercress along with chlorzoxazone might increase the effects and side effects of chlorzoxazone.
Lithium interacts with Watercress
Watercress might have an effect like a water pill or "diuretic." Taking watercress might decrease how well the body gets rid of lithium. This could increase how much lithium is in the body and result in serious side effects. Talk with your healthcare provider before using this product if you are taking lithium. Your lithium dose might need to be changed.

Dosing

The appropriate dose of watercress depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for watercress. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

Wichtl MW. Herbal Drugs and Phytopharmaceuticals. Ed. N.M. Bisset. Stuttgart: Medpharm GmbH Scientific Publishers, 1994.

McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.

Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.

Leclercq I, Desager JP, Horsmans Y. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin Pharmacol Ther 1998;64:144-9.

Hecht SS, Chung FL, Richie JP Jr., et al. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 1995;4:877-84.

Bolton-Smith C, Price RJ, Fenton ST, et al. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr 2000;83:389-99.

Conaway, C. C., Yang, Y. M., and Chung, F. L. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002;3(3):233-255.

Pereira, C., Li, D., and Sinclair, A. J. The alpha-linolenic acid content of green vegetables commonly available in Australia. Int J Vitam.Nutr.Res 2001;71(4):223-228.

Botting, K. J., Young, M. M., Pearson, A. E., Harris, P. J., and Ferguson, L. R. Antimutagens in food plants eaten by Polynesians: micronutrients, phytochemicals and protection against bacterial mutagenicity of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline. Food Chem.Toxicol. 1999;37(2-3):95-103.

Getahun, S. M. and Chung, F. L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol.Biomarkers Prev. 1999;8(5):447-451.

Mesquita, V. C., Serra, C. M., Bastos, O. M., and Uchoa, C. M. [The enteroparasitic contamination of commercial vegetables in the cities of Niteroi and Rio de Janeiro, Brazil]. Rev Soc Bras.Med Trop. 1999;32(4):363-366.

Hecht, S. S., Carmella, S. G., and Murphy, S. E. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol.Biomarkers Prev. 1999;8(10):907-913.

Rondelaud, D., Dreyfuss, G., Bouteille, B., and Darde, M. L. Changes in human fasciolosis in a temperate area: about some observations over a 28-year period in central France. Parasitol.Res 2000;86(9):753-757.

Rose, P., Faulkner, K., Williamson, G., and Mithen, R. 7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Carcinogenesis 2000;21(11):1983-1988.

Chung, F. L., Conaway, C. C., Rao, C. V., and Reddy, B. S. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000;21(12):2287-2291.

Sanchez-Sosa, S., Rojas-Ortega, S., Reed-San Roman, G., and Torres-Santana, M. A. [Massive hepatobiliary fascioliasis]. Rev Gastroenterol.Mex. 2000;65(4):179-183.

van Daele, P. L., Madretsma, G. S., and van Agtmael, M. A. [Stomach ache and fever after consumption of watercress in Turkey: fascioliasis]. Ned.Tijdschr.Geneeskd. 9-29-2001;145(39):1896-1899.

Cosme, A., Ojeda, E., Cilla, G., Torrado, J., Alzate, L., Beristain, X., Orive, V., and Arenas, J. [Fasciola hepatica. study of a series of 37 patients]. Gastroenterol.Hepatol. 2001;24(8):375-380.

Martinez-Bebert, K., Rodriguez-Baez, R., Pila-Perez, R., Pila-Pelaez, R., and Tamakloe, K. [Hepatic hematoma caused by fascioliasis]. Gac.Med Mex. 2002;138(3):271-274.

Dreyfuss, G., Vignoles, P., Abrous, M., and Rondelaud, D. Unusual snail species involved in the transmission of Fasciola hepatica in watercress beds in central France. Parasite 2002;9(2):113-120.

Christmann, M., Henrich, R., Mayer, G., and Ell, C. [Infection with fasciola hepatica causing elevated liver-enzyme results and eosinophilia - serologic and endoscopic diagnosis and therapy]. Z.Gastroenterol. 2002;40(9):801-806.

Hu, R., Kim, B. R., Chen, C., Hebbar, V., and Kong, A. N. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003;24(8):1361-1367.

Cosme, A., Ojeda, E., Poch, M., Bujanda, L., Castiella, A., and Fernandez, J. Sonographic findings of hepatic lesions in human fascioliasis. J Clin Ultrasound 2003;31(7):358-363.

Chung, F. L., Morse, M. A., Eklind, K. I., and Lewis, J. Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol.Biomarkers Prev. 1992;1(5):383-388.

Sapunar, J., Latorre, R., Guerra, M., and Defilippi, C. [Clinical considerations on 2 cases of hepatic fascioliasis. Importance of the imaging examinations]. Bol.Chil.Parasitol. 1992;47(3-4):70-76.

de Gorgolas, M., Torres, R., Verdejo, C., Garay, J., Robledo, A., Ponte, M. C., and Fernandez Guerrero, M. L. [Fasciola hepatica infestation. Biopathology and new diagnostic and therapeutic aspects]. Enferm.Infecc.Microbiol.Clin 1992;10(9):514-519.

Chiao, J. W., Wu, H., Ramaswamy, G., Conaway, C. C., Chung, F. L., Wang, L., and Liu, D. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004;25(8):1403-1408.

Carrada-Bravo, T. [Fascioliasis: diagnosis, epidemiology and treatment]. Rev Gastroenterol.Mex. 2003;68(2):135-142.

Yilmaz, H. and Godekmerdan, A. Human fasciolosis in Van province, Turkey. Acta Trop. 2004;92(2):161-162.

Dobrucali, A., Yigitbasi, R., Erzin, Y., Sunamak, O., Polat, E., and Yakar, H. Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis. World J Gastroenterol. 10-15-2004;10(20):3076-3077.

Alvarez-Chacon, R., Garcia-Rosales, J. J., de la Cruz-Otero MC, Wong-Chio, M., Cabrera-Bravo, M., Gomez-Gomez, J. V., and Gamez-Aranda, V. [Fascioliasis in children. A study of 10 cases]. Bol.Med Hosp.Infant Mex. 1992;49(6):365-371.

Mailles, A., Capek, I., Ajana, F., Schepens, C., Ilef, D., and Vaillant, V. Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation. Epidemiol.Infect. 2006;134(5):942-945.

Cruz, Lopez O., Adan, Pimentel A., Tamariz Cruz, O. J., Munoz, Lopez A., Cruz Lopez, M. C., Cruz Lopez, M. E., and Munoz, Lopez S. [Hepatic fasciolasis diagnosed in state phase]. Rev Gastroenterol Mex. 2006;71(1):59-62.

el Shazly, A. M., Handousa, A. E., Youssef, M. E., Rizk, H., and Hamouda, M. M. Human fascioliasis: a parasitic health problem in Dakahlia Governorate, Egypt. J Egypt.Soc Parasitol. 1991;21(2):553-559.

Cosme, A., Alzate, L., Orive, V., Recasens, M., Torrado, J., Ruiz, I., and Arenas, J. [Laparoscopic findings in liver fascioliasis. Study of 13 cases]. Rev Esp.Enferm.Dig. 1990;78(6):359-362.

Diaz, J., Pina, B., Lastre, M., Rivera, L., and Perez, O. [Epidemic human fascioliasis. Cuba 1983. VI. Clinical study of 40 children in the Hospital Provincial of Sagua la Grande]. G.E.N. 1990;44(4):385-388.

Borie, C., Corona, S., Garin, A., Olea, P., Salcedo, M., Perez, C., and Apt, W. [A family outbreak of acute hepatic fascioliasis]. Rev Med Chil. 1990;118(1):67-72.

Diamond, S. P., Wiener, S. G., and Marks, J. G., Jr. Allergic contact dermatitis to nasturtium. Dermatol.Clin. 1990;8(1):77-80.

Delasalle, P., Beytout, J., Cambon, M., and Bommelaer, G. [Distomatosis: diagnosis and treatment]. Rev Prat. 1-21-1990;40(3):230-236.

Rivera, J. V. and Bermudez, R. H. Radionuclide imaging of the liver in human fascioliasis. Clin Nucl.Med 1984;9(8):450-453.

Croese, J., Chapman, G., and Gallagher, N. D. Evolution of fascioliasis after eating wild watercress. Aust.N.Z.J.Med. 1982;12(5):525-527.

Bendezu, P., Frame, A., and Hillyer, G. V. Human fascioliasis in Corozal, Puerto Rico. J Parasitol. 1982;68(2):297-299.

Carmella, S. G., Borukhova, A., Akerkar, S. A., and Hecht, S. S. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol.Biomarkers Prev. 1997;6(2):113-120.

Derrick, E. and Darley, C. Contact dermatitis to nasturtium. Br.J Dermatol 1997;136(2):290-291.

Hecht, S. S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ.Health Perspect. 1997;105 Suppl 4:955-963.

Narain, K., Biswas, D., Rajguru, S. K., and Mahanta, J. Human distomatosis due to Fasciola hepatica infection in Assam, India. J Commun.Dis 1997;29(2):161-165.

Chung, F. L., Jiao, D., Conaway, C. C., Smith, T. J., Yang, C. S., and Yu, M. C. Chemopreventive potential of thiol conjugates of isothiocyanates for lung cancer and a urinary biomarker of dietary isothiocyanates. J Cell Biochem.Suppl 1997;27:76-85.

Brinker, F. Herb Contraindications and Drug Interactions. 1998;2nd edition.

Gruenwald, J. PDR for Herbal Medicines. 1998;1st ed.

Wichtl, MW. Herbal Drugs and Phytopharmaceuticals. 1994.

Camponogara C, Silva CR, Brusco I, et al. Nasturtium officinale R. Br. effectively reduces the skin inflammation induced by croton oil via glucocorticoid receptor-dependent and NF-?B pathways without causing toxicological effects in mice. J Ethnopharmacol. 2019 Jan 30;229:190-204. Epub 2018 Oct 17.

Clemente M, Miguel MD, Felipe KB, et al. Biomarkers of oxidative stress and inflammation in people with a physical disability treated with a standardized extract of Nasturtium officinale: a randomized, double-blind, and placebo-controlled trial. Phytother Res. 2020;34(10):2756-65.

Schulze H, Hornbacher J, Wasserfurth P, et al. Immunomodulating effect of the consumption of watercress (Nasturtium officinale) on exercise-induced inflammation in humans. Foods. 2021;10(8):1774.

Sedaghattalab M, Razazan M, Sadeghi H, et al. Effects of Nasturtium officinale extract on antioxidant and biochemical parameters in hemodialysis patients: a randomized double-blind clinical trial. Evid Based Complement Alternat Med. 2021;2021:1632957.

Shokraei S, Khandouzi N, Sina Z, Nasrollahzadeh J. The acute effect of incorporating lettuce or watercress into a moderately high-fat meal on postprandial lipid, glycemic response, and plasma inflammatory cytokines in healthy young men: a randomized crossover trial. Lipids Health Dis. 2021;20(1):66.

Clemente M, Miguel MD, Felipe KB, et al. Effect of watercress extract supplementation on lipid profile and oxidative stress markers in overweight people with physical disability: A randomized, double-blind, and placebo-controlled trial. Phytother Res. 2021;35(4):2211-2219.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.